510(k) K924006
K924006 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on Dec 29, 1992. The device falls under product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Baxter Healthcare Corp has 507 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 29, 1992
- Date Received
- Aug 10, 1992
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
- Device Class
- Class I
- Regulation Number
- 866.3330
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
Need the full FDA record for Baxter Healthcare Corp? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.